"10.1371_journal.ppat.1003524","plos pathogens","2013-08-08T00:00:00Z","Lucien Rufener; Nicola Bedoni; Roland Baur; Samantha Rey; Dominique A Glauser; Jacques Bouvier; Robin Beech; Erwin Sigel; Alessandro Puoti","Novartis Centre de Recherche Sant√© Animale, St. Aubin, Switzerland; Institute of Parasitology, Macdonald College, McGill University, Ste Anne de Bellevue, Quebec, Canada; Department of Biology, University of Fribourg, Fribourg, Switzerland; Institute for Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland","Conceived and designed the experiments: LR NB RBa SR ES DAG RBe JB AP. Performed the experiments: LR NB RBa SR DAG AP. Analyzed the data: LR NB SR RBa ES RBe DAG AP. Contributed reagents/materials/analysis tools: LR JB AP. Wrote the paper: LR ES AP.","I have read the journals policy and have the following conflicts: LR and JB authors are currently under the employment of Novartis Animal Health, which provided funds and equipment to conduct part of the studies and where they receive salary, benefits and stock. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials. Monepantel has been developed at Novartis Animal Health. The use of AADs for veterinary purposes is patented (WO2002049641).","2013","08","Lucien Rufener","LR",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
